All Stories

  1. Cognitive Rehabilitation For Early-Stage Dementia: A Review
  2. Artificial Intelligence in The Management of Neurodegenerative Disorders
  3. Concise Review on Scientific Approaches to Burns and Scars
  4. Smartphone Addiction among Students and its Harmful Effects on Mental Health, Oxidative Stress, and Neurodegeneration towards Future Modulation of Anti-Addiction Therapies: A Comprehensive Survey based on SLR, Research Questions, and Network Visualizat...
  5. Antifungal Activity of Plant Secondary Metabolites on Candida albicans: An Updated Review
  6. Novel Approaches for the Application of Herbs for Skin Care
  7. A Critical Analysis of Quercetin as the Attractive Target for the Treatment of Parkinson's Disease
  8. Can We Use mTOR Inhibitors for COVID-19 Therapy?
  9. Nanoparticles Mediated Target-specific Drug Delivery in Prostate Cancer: An In-depth Review
  10. LPS/TLR4 Pathways in Breast Cancer: Insights into Cell Signalling
  11. Epigenetics of Triple-Negative Breast Cancer via Natural Compounds
  12. Bacterial Nanocellulose based Wound Dressings: Current and Future Prospects
  13. Total Stromal Fraction (TSF) - Fortified Adipose Tissue-Derived Stem Cells Source: An Emerging Regenerative Realm Against COVID-19 Induced Pulmonary Compromise
  14. Trends in Photocatalysis Research from the Year 2000 to 2020
  15. Interaction of Ectodomain of Respiratory Syncytial Virus G Protein with TLR2/ TLR6 Heterodimer: An In vitro and In silico Approach to Decipher the Role of RSV G Protein in Pro-inflammatory Response against the Virus
  16. Clinical Review of COVID-19; Pathogenesis, Diagnosis, and Management
  17. Therapeutic Management of COVID-19 Patients: Clinical Manifestation and Limitations
  18. Study of Nutraceuticals and Phytochemicals for the Management of Alzheimer's Disease: A Review
  19. Synopsis of Pharmotechnological Approaches in Diagnostic and Management Strategies for Fighting Against COVID-19
  20. Coronavirus Disease-2019 (COVID-19) in 2020: A Perspective Study of a Global Pandemic
  21. Natural Products Homoharringtonine and Emetine Alkaloids as SARS-CoV-2 Treatment Options
  22. Emerging Therapeutic Approaches to COVID-19
  23. Prospective Function of Different Antioxidant Containing Natural Products in the Treatment of Neurodegenerative Diseases
  24. Promiscuous Biological Features of Newly Emerged SARS-CoV-2 Facilitate its Unrestrained Outbreak: An Update
  25. Melatonin and Sleep Disturbances in Alzheimer’s Disease
  26. Decoding the Inter-Relationship between Sleep Disorders and Alzheimer’s Disease Pathogenesis
  27. Cardiac Biomarkers in Stroke, Alzheimer’s Disease, and Other Dementia. Are They of Use? A Brief Overview of Data from Recent Investigations
  28. Alzheimer Disease and Sleep Disorders: Insights into the Possible Disease Connections and the Potential Therapeutic Targets (Part II)
  29. Functional Neuroproteomics: An Imperative Approach for Unravelling Protein Implicated Complexities of Brain
  30. Cellular and Molecular Mechanisms of Dementia: Decoding the Causal link of Diabetes Mellitus in Alzheimer’s Disease
  31. Sleep Disorders Research From 1945 to 2020: A Bibliometric Analysis
  32. Elachi Lemon (Citrus limon) Peel and Pulp: Antioxidant, Antimicrobial, Anticoagulant Activities, Bioactive Compounds, Minerals, and Heavy Metals
  33. Antimicrobial and Antifungal Properties of Leaves to Root Extracts and Saponin Fractions of Chlorophytum borivilianum
  34. Diabetic Cardiomyopathy: From Mechanism to Management in a Nutshell
  35. Prospects for Discovering the Secondary Metabolites of Cordyceps Sensu Lato by the Integrated Strategy
  36. Emergence and Reemergence of Human Coronaviruses: Spike Protein as the Potential Molecular Switch and Pharmaceutical Target
  37. Bibliometric Analysis of Current Drug Metabolism: The Twentieth Anniversary from 2000-2019
  38. COVID-19 Outbreak and Emerging Management through Pharmaceutical Therapeutic Strategy
  39. The Emergence of Human Pathogenic Coronaviruses: Lectins as Antivirals for SARS-CoV-2
  40. Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part-I)
  41. Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19
  42. A critical transcription factor NF-κB as a cancer therapeutic target and its inhibitors as cancer treatment options
  43. Role of ATP-Binding Cassette Transporter Proteins in CNS Tumors: Resistance- Based Perspectives and Clinical Updates
  44. Ajmalicine and its Analogues Against AChE and BuChE for the Management of Alzheimer’s Disease: An In-silico Study
  45. Cross-Interplay between Osmolytes and mTOR in Alzheimer's Disease Pathogenesis
  46. Edible Nuts for Memory
  47. The Language Development Via FOXP2 in Autism Spectrum Disorder: A Review
  48. Current Challenges in the Management of Neurological Disorders (Part-II)
  49. Computational Analysis of Dynamical Fluctuations of Oncoprotein E7 (HPV 16) for the Hot Spot Residue Identification Using Elastic Network Model
  50. Tumor angiogenesis and VEGFR-2: mechanism, pathways and current biological therapeutic interventions
  51. A Study on Serological Reactivity Profile of Different Antigen Preparations with Bancroftian filariasis Human Infection Sera
  52. Elucidation of PLK1 Linked Biomarkers in Oesophageal Cancer Cell Lines: A Step Towards Novel Signaling Pathways by p53 and PLK1- Linked Functions Crosstalk
  53. Synthesis of Silver Nanoparticles using Euphorbia wallichii Extract and Assessment of their Bio-functionalities
  54. Versatile and Valuable Utilization of Amidohydrolase L-glutaminase in Pharma and Food industries: A Review
  55. Stem Cells in Tumour Microenvironment Aid in Prolonged Survival Rate of Cancer Cells and Developed Drug Resistance: Major Challenge in Osteosarcoma Treatment
  56. Challenges in the Discovery of Novel Therapeutic Agents in Cancer (Part III)
  57. A Computational Study of Natural Compounds from Bacopa monnieri in the Treatment of Alzheimer's Disease
  58. Role of Dietary Antioxidants in Neurodegenerative Diseases: Where are We Standing?
  59. Multiple Risk Factors: A Challenge in the Management of Autism
  60. Tubulin Proteins in Cancer Resistance: A review
  61. Challenges in the Discovery of Novel Therapeutic Agents in Cancer
  62. Challenges in the Discovery of Novel Therapeutic Agents in Cancer
  63. The Structure and Function of α, β and γ-Secretase as Therapeutic Target Enzymes in the Development of Alzheimer’s Disease: A Review
  64. Non-coding RNAs in Lung Cancer Chemoresistance
  65. Therapeutic Study of Phytochemicals Against Cancer and Alzheimer’s Disease Management
  66. Molecular Docking studies reveals Rhein from rhubarb (Rheum rhabarbarum) as a putative inhibitor of ATP-binding Cassette Super Family G member 2
  67. In Silico Structure Modeling and Molecular Docking Analysis of Phosphoribosyl Pyrophosphate Amidotransferase (PPAT) with Antifolate Inhibitors
  68. Nonpharmacologic Interventions in Prevention and Treatment of Hypertension
  69. Single Probiotic versus Multiple Probiotics - A Debate On Current Scenario for Alleviating Health Benefits
  70. Effect of Diterpenes on Hepatic System
  71. Influence of Hormones on Sjögren’s Syndrome
  72. From Molecular Mechanism to the Etiology of Sjogren Syndrome
  73. Updates on Neurodegenrative and Metabolic Disorders: Synthetic, Biological and Computational Aspects
  74. Essential Oils: Extraction Techniques, Pharmaceutical And Therapeutic Potential - A Review
  75. Preclinical Hepatoprotective Effect of Herbalism Against Ethanol Induced Hepatotoxicity: A Review
  76. From Oxidative Stress to Ageing via Lifestyle, Nutraceuticals, Polypharmacy, and Neuropsychological Factors
  77. Relationship between CNS and Immunology: Correlation with Psychology
  78. Antiplatelet Potential of Plant-Derived Glycosides as Possible Lead Compounds
  79. Advanced Glycation End Products (AGEs), Glutathione and Breast Cancer: Factors, Mechanism and Therapeutic Interventions
  80. Potential Application of Venom Proteins in Designing of Medicines for Treating Human Neurodegenerative Disorders
  81. A Synopsis on the Role of Human Papilloma Virus Infection in Cervical Cancer
  82. Anti-cancer Effects of Metformin: Recent Evidences for its Role in Prevention and Treatment of Cancer
  83. Structure Activity Relationship of Venom Toxins Targeting Potassium Channels
  84. Topical Discoveries on Multi-Target Approach to Manage Alzheimer’s Disease
  85. Frontier View on Nanotechnological Strategies for Neuro-therapy
  86. Potentiating Effect of Ethnomedicinal Plants Against Proliferation on Different Cancer Cell Lines
  87. An Insight into the Therapeutic Potential of Major Coffee Components
  88. Inhibition of Neurogenesis by Zika Virus Infection
  89. Antidepressant Potential of Peptides: New Insights as Future Therapeutic
  90. In-silico Studies of Isolated Phytoalkaloid Against Lipoxygenase: Study Based on Possible Correlation
  91. Effects of Ascorbic Acid on Tax, NF-κB and MMP-9 in Human T-cell Lymphotropic Virus Type 1 Positive Malignant T-Lymphocytes
  92. Role Of Angiogenenic Growth Factors In Psoriasis: A Review
  93. Design and Delivery of Therapeutic siRNAs: Application to MERS-Coronavirus
  94. Anthocyanins and its biological & therapeutic characters
  95. Methods of Screening-Purification and Antimicrobial Potentialities of Bacteriocin in Health Care
  96. Pharmacological and Toxicological Profile of Harmane-β-Carboline Alkaloid: Friend or Foe
  97. Recent Development and Future Prospects of Plant-Based Vaccines
  98. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease
  99. Translational Shift of HSP90 as a Novel Therapeutic Target from Cancer to Neurodegenerative Disorders: An Emerging Trend in the Cure of Alzheimer's and Parkinson's Diseases
  100. Diabetes Mellitus and Male Aging: Pharmacotherapeutics and Clinical Implications
  101. Screening and Elucidation of Selected Natural Compounds for Anti- Alzheimer's Potential Targeting BACE-1 Enzyme: A Case Computational Study
  102. Inhibition of Butyrylcholinesterase with Fluorobenzylcymserine, An Experimental Alzheimer's Drug Candidate: Validation of Enzoinformatics Results by Classical and Innovative Enzyme Kinetic Analyses
  103. Meet Our Regional Editor
  104. Common Therapeutic Modalities Against Diabetes and Associated Cardiovascular Disease
  105. Thrombotic Management of Antiphospholipid Syndrome: Towards Novel Targeted Therapies
  106. EDITORIAL: Current Views on Neurodegeneration: Computational to Clinical Research
  107. Nanoparticles as a Carrier System for Drug Delivery Across Blood Brain Barrier
  108. A Review on Nano-Antimicrobials: Metal Nanoparticles, Methods and Mechanisms
  109. Editorial: Frontier View on Drug Discoveries for Different Diseases - Part II
  110. Neuroinflammation in Alzheimer's Disease
  111. Editorial (Thematic Issue: Medicinal Chemistry: Neurological and Endocrinological Disorders)
  112. Super aggregated form of Amphotericin B: a novel way to increase its therapeutic index
  113. Conotoxins: Structure, Therapeutic Potential and Pharmacological Applications
  114. Inflammatory Process in Alzheimer's and Parkinson's Diseases: Central Role of Cytokines
  115. Computer Aided Drug Design: Success and Limitations
  116. Treatment of psoriasis by using Hijamah: A case report
  117. Biological aspect of various global health issues
  118. Dear Global Researchers in the disciple of Genetics, Molecular, Cellular Biology and related sciences
  119. An Overview on Potential Neuroprotective Compounds for Management of Alzheimer’s Disease
  120. Nanotechnology-based approaches in anticancer research
  121. Editorial [Hot Topic: Status of Tyrosine Hydroxylase in the Healthy and Parkinson's Brain (Guest Editor: Mohammad Amjad Kamal)]
  122. Investigation of the effect of lannate on kinetic parameters of acetylcholinesterase: Slightly concave mixed-type of inhibition system
  123. Dual temperature model for the estimation of energetics parameters for acetylcholinesterase inhibition by cyclophosphamide
  124. Effect of malathion on kinetic parameters of acetylcholinesterase (EC 3.1.1.7)In vitro
  125. Effect of sevin on kinetic parameters of camel retina acetylcholinesterase
  126. The inhibitory effect of cyclophosphamide on camel retina acetylcholinesterase activity